Interpreting Treatment Effects From Clinical Trials in the Context of Real-World Risk Information-Reference-Cited by-同舟云学术

Interpreting Treatment Effects From Clinical Trials in the Context of Real-World Risk Information

Published:2014-03-01 Issue:3 Volume:174 Page:391
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

O’Hare Ann M.¹,Hotchkiss John R.²,Kurella Tamura Manjula³,Larson Eric B.⁴,Hemmelgarn Brenda R.⁵,Batten Adam⁶,Do Thy P.⁷,Covinsky Kenneth E.⁸

Affiliation:

1. Department of Medicine, Department of Veterans Affairs Puget Sound Healthcare System, Seattle, Washington2Department of Medicine, University of Washington, Seattle3Group Health Research Institute, Seattle, Washington

2. Veterans Engineering Resource Center, Department of Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennyslvania5Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania

3. Department of Medicine, Department of Veterans Affairs Palo Alto Healthcare System, Palo Alto, California7Department of Medicine, Stanford University Medical Center, Palo Alto, California

4. Department of Medicine, University of Washington, Seattle3Group Health Research Institute, Seattle, Washington

5. Department of Medicine, University of Calgary, Calgary, Alberta, Canada

6. Department of Medicine, Department of Veterans Affairs Puget Sound Healthcare System, Seattle, Washington

7. Department of Medicine, Department of Veterans Affairs Puget Sound Healthcare System, Seattle, Washington9currently with Amgen, Thousand Oaks, California

8. Department of Medicine, Department of Veterans Affairs Medical Center, San Francisco, San Francisco, California11Department of Medicine, University of California, San Francisco

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteinuria Assessment and Therapeutic Implementation in Chronic Kidney Disease Patients—A Clinical Audit on KDIGO (“Kidney Disease: Improving Global Outcomes”) Guidelines;Journal of Clinical Medicine;2024-09-09

2. Longitudinal Analysis of Renal Function Changes in Elderly Populations: Health Status Evaluation and Risk Factor Assessment;Clinical Interventions in Aging;2024-07

3. Representation of Real‐World Adults With Chronic Kidney Disease in Clinical Trials Supporting Blood Pressure Treatment Targets;Journal of the American Heart Association;2024-04-02

4. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk;The Lancet Regional Health - Europe;2024-03

5. Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?;Current Opinion in Nephrology & Hypertension;2024-02-23